Chronic pain and narcotics

Turk D. Clinicians’ attitudes about prolonged use of opioids and the issue of patient heterogeneity. J Pain Symptom Manage. 1996;11:218–30.PubMedCrossRefGoogle Scholar

Olt GJ. Managing pain and psychological issues in palliative care. Best Pract Res Clin Obstet Gynaecol. 2001;15:235–51.PubMedCrossRefGoogle Scholar

Warfield CA. Controlled-release morphine tablets in patients with chronic cancer pain: a narrative review of controlled clinical trials. Cancer. 1998;82:2299–306.PubMedCrossRefGoogle Scholar

Mercadante S. World Health Organization Guidelines: problem areas in cancer pain management. Cancer Control. 1999;6:191–7.PubMedGoogle Scholar

Walsh D. Pharmacological management of cancer pain. Semin Oncol. 2000;27:45–63.PubMedGoogle Scholar

Grossman S, Sheidler V. Cancer pain. In: Abeloff MD, ed. Clinical Oncology, 2^nd ed. New York: Churchill Livingstone, Inc. 2000;544–7.Google Scholar

American Pain Society Quality of Care Committee. Quality improvement guidelines for the treatment of acute pain and cancer pain. JAMA. 1995;274:1874–80.CrossRefGoogle Scholar

Working Group of the Ethical Issues in Medicine Committee of the Royal College of Physicians. Principles of pain control in palliative care for adults. Guidance prepared by a Working Group of the Ethical Issues in Medicine Committee of the Royal College of Physicians. J Royal Coll Physicians. 2000;34:350–2.Google Scholar

Abrahm JL. Management of pain and spinal cord compression in patients with advanced cancer. ACP-ASIM End-of-life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med. 1999;131:37–46.PubMedGoogle Scholar

Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O’Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173–9.PubMedCrossRefGoogle Scholar

Adams NJ, Plane MB, Fleming MF, Mundt MP, Saunders LA, Stauffacher EA. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage. 2001;22:791–6.PubMedCrossRefGoogle Scholar

Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13:116–37.PubMedCrossRefGoogle Scholar

Gallagher RM, Verma S. Managing pain and comorbid depression: a public health challenge. Semin Clin Neuropsychiatry. 1999;4:203–20.PubMedGoogle Scholar

Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: results from the Baltimore Epidemiologic Catchment area follow-up study. Arch Gen Psychiatry. 2000;57:945–50.PubMedCrossRefGoogle Scholar

Fishbain DA, Rosomoff HL, Rosomoff RS. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain. 1992;8:77–85.PubMedCrossRefGoogle Scholar

Aronoff GM. Opioids in chronic pain management: is there a significant risk of addiction? Curr Rev Pain. 2000;4:112–21.PubMedGoogle Scholar

Smith LC. Dual diagnosis. Effective recognition and management of severe mental illness and substance abuse. JAAPA 2001;14:22–4, 27–30, 35–6.PubMedGoogle Scholar

Watkins KE, Burnam A, Kung FY, Paddock S. A national survey of care for persons with co-occurring mental and substance abuse disorders. Psychiatr Serv. 2001;52:1062–8.PubMedCrossRefGoogle Scholar

Compton WM III, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict. 2000;9:126–34.PubMedCrossRefGoogle Scholar

Lehman AF, Myers CP, Corty E. Assessment and clarification of patients with psychiatric and substance abuse syndromes. 1989. Psychiatr Serv. 2000;15:1119–25.CrossRefGoogle Scholar

McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther. 2001;8:181–6.PubMedCrossRefGoogle Scholar

Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50:145–51.PubMedGoogle Scholar

Turk DC, Brody MC, Okifuji EA. Physicians’ attitudes and practices regarding the long-term prescribing of opioids for noncancer pain. Pain. 1994;59:201–8.PubMedCrossRefGoogle Scholar

Schofferman J. Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin. J Pain Symptom Manage. 1993;8:279–88.PubMedCrossRefGoogle Scholar

Portenoy RK. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 1990;5(Suppl 1):46S-62S.Google Scholar

Sanders SH, Harden RN, Benson SE, Vicente PJ. Clinical practice guidelines for chronic non-malignant pain syndrome patients II: An evidence-based approach. J Back Musculoskeletal Rehabil. 1999;13:47–58.Google Scholar

Benjamin LJ, Dampier CC, Jacox AK, et al. Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease. [APS Clinical Practice Guideline Series No. 1]. Glenview, Ill: American Pain Society; 1999.Google Scholar

Practice guidelines for chronic pain management. A report by the American Society of Anesthesiologists Task Force on Pain Management. Chronic Pain Section. Anesthesiology. 1997;86:995–1004.CrossRefGoogle Scholar

Hagen N, Flynne P, Hays H, MacDonald N. Guidelines for managing chronic non-malignant pain. Opioids and other agents. College of Physicians and Surgeons of Alberta. Can Fam Physician. 1995;41:49–53.PubMedGoogle Scholar

American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain. 1997;13:6–8.CrossRefGoogle Scholar

Portenoy R. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203–17.PubMedCrossRefGoogle Scholar

Jamison RN. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 1996;11:231–41.PubMedCrossRefGoogle Scholar

Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853–60.PubMedCrossRefGoogle Scholar

Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID’s: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain. 2001;91:23–31.PubMedCrossRefGoogle Scholar

Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine. 1998;23:2591–600.PubMedCrossRefGoogle Scholar

Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322:1154–8.PubMedCrossRefGoogle Scholar

Dellemijn PL, Vanneste JA. Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 1997;349:753–8.PubMedCrossRefGoogle Scholar

Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837–41.PubMedGoogle Scholar

Arkinstall W, Sandler A, Goughnour B, Babul N, Harsanyi Z, Darke AC. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain. 1995;62:169–78.PubMedCrossRefGoogle Scholar

Moulin DE, Iezzi A, Amireh R, Sharpe WK, Boyd D, Merskey H. Randomised trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143–7.PubMedCrossRefGoogle Scholar

Tough P. The oxycontin underground: how a prescription pain-killer is turning into a pernicious street drug. The New York Times Magazine. July 29, 2001:31–63.Google Scholar